CDC logo Tuberculosis Information CD-ROM   Image of people
   
1
spacer image

Text for Figures and Slides in TB Behavioral and Social Science Research Forum Proceedings

POTENTIAL FUNDING OPPORTUNITIES
Kathryn O’Toole, M.B.A.
Associate Director of Management and Operations,
Division of Tuberculosis Elimination,
Centers for Disease Control and Prevention

Slide #1: DTBE Appropriation and Funding    

Kate O’Toole, MBA
Associate Director for Management and Operations    

Return to Slide Set

Slide #2: FY2003 Congressional Appropriation to CDC for Tuberculosis

  • FY2003 Appropriation = $136,514,000 (includes S&E)
  • Earmark = $125,000 in PHPPO’s budget

Return to Slide Set

Slide #3: FY 2003 Gross-to-Net CDC Funding (Appropriation including S & E)

  • Rescission = $887,341
  • Indirect = $7,159,327
  • 1x tap for GAP = $270,000
  • To other divisions = $19,870
  • NCHSTP overhead = $2,776,112
  • Adjust for GAP overhead = $62,633
  • HIV = $10,728,670
  • Onondaga after taps = $119,573

Return to Slide Set

Slide #4: USAID Funding to DTBE

  • USAID total funding = $2,551,246
  • Overhead tap (15%) = $382,687
  • Balance = $2,168,559

Return to Slide Set

Slide #5: This slide shows a pie chart of the discretionary funding to DTBE/NCHSTP. The divisions of the chart include TB, HIV, and USAID.

Return to Slide Set

Slide #6: Project Concept Solicitation: April 1, 2003

  • DTBE solicited research concepts from CDC, TBESC, and TBTC investigators.
  • A standardized “project concept form” was used. 
  • For CDC staff, all funding proposals (research and other) were submitted, but only research proposals were forwarded to the CDC/TBESC research concept reviewers.

Return to Slide Set

Slide #7: Determination of Appropriateness for TBESC: Early April 2003

  • TBESC Research Chair and the DTBE Associate Director for Science (ADS) determined if a appropriate for TBESC. 

Return to Slide Set

Slide #8: TBESC RC Review of Project Concepts: April 10, 2003

  • Before and at the TBESC semi-annual meeting, the RC reviewed the research concepts that were considered appropriate for TBESC. 
  • Prioritized each project concept by giving it a score of high, medium, or low. 
  • TBESC and CDC investigators whose concepts were ranked high or medium were allowed to revise and resubmit their project concepts incorporating the RC’s comments/recommendations.

Return to Slide Set

Slide #9: TB Leads review of project concepts: Early May

  • The DTBE Senior Staff independently reviewed the project concepts using the same ranking system as the RC:  low, medium and high with comments/recommendations.
  • They ranked concepts based on the merit of the concept to the Division and its mission, and the comprehensiveness of collaboration.

Return to Slide Set

Slide #10: Joint TBESC RC/DTBE TB Leads meeting:  May 12, 2003

  • The joint TBESC RC/DTBE TB Leads group met in Atlanta to discuss the TBESC RC/TB Leads report.
  • The final report to the TBESC and CDC investigators included the summary ranking of the TBESC RC and TB Leads group (including discrepant results) and recommendations to the PIs from each group. 
  • Investigators whose concepts were ranked high by both groups were encouraged to develop their concepts into full TB Leads proposals. 
  • A number of investigators whose proposals were ranked high and medium were also encouraged to develop their concepts into full proposals.

Return to Slide Set

Slide #11: Submission of TB Leads proposals:  October 1, 2003

  • TBESC and CDC investigators and their collaborators developed and submitted proposals. 
  • Only investigators who submitted project concepts were allowed to submit TB Leads proposals.

Return to Slide Set

Slide #12: TB Leads Evaluation: October 14, 2003

  • The proposals were reviewed by the DTBE TB Leads group and ranked.  This included both research proposals and non-research related proposals that did not go through the TBESC review process.  Final funding decisions will be made when the congressional budget for TB is available but no projects are expected to be funded in FY2004.

Return to Slide Set

Slide #13: FY2005

  • Similar process
  • Later initial deadlines
  • Earlier decisions

Return to Slide Set

 

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333